Annual Net Income
-$5.09 M
+$1.23 M+19.41%
December 31, 2023
Summary
- As of February 26, 2025, LIXT annual net profit is -$5.09 million, with the most recent change of +$1.23 million (+19.41%) on December 31, 2023.
- During the last 3 years, LIXT annual net income has fallen by -$1.82 million (-55.81%).
- LIXT annual net income is now -15362.01% below its all-time high of -$32.90 thousand, reached on December 31, 2005.
Performance
LIXT Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$986.00 K
+$24.90 K+2.46%
September 30, 2024
Summary
- As of February 26, 2025, LIXT quarterly net profit is -$986.00 thousand, with the most recent change of +$24.90 thousand (+2.46%) on September 30, 2024.
- Over the past year, LIXT quarterly net income has stayed the same.
- LIXT quarterly net income is now -725.63% below its all-time high of $157.60 thousand, reached on December 31, 2010.
Performance
LIXT Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$4.00 M
+$32.80 K+0.81%
September 30, 2024
Summary
- As of February 26, 2025, LIXT TTM net profit is -$4.00 million, with the most recent change of +$32.80 thousand (+0.81%) on September 30, 2024.
- Over the past year, LIXT TTM net income has stayed the same.
- LIXT TTM net income is now -14661.99% below its all-time high of -$27.10 thousand, reached on March 31, 2006.
Performance
LIXT TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
LIXT Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +19.4% | 0.0% | 0.0% |
| 3 y3 years | -55.8% | +40.9% | +34.9% |
| 5 y5 years | -138.5% | +40.9% | +34.9% |
LIXT Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +24.4% | -1.5% | +51.4% | at high | +40.5% |
| 5 y | 5-year | -108.5% | +24.4% | -206.1% | +51.4% | -85.4% | +40.5% |
| alltime | all time | <-9999.0% | +24.4% | -725.6% | +51.4% | <-9999.0% | +40.5% |
Lixte Biotechnology Holdings Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$986.00 K(-2.5%) | -$4.00 M(-0.8%) |
| Jun 2024 | - | -$1.01 M(+4.1%) | -$4.03 M(-14.0%) |
| Mar 2024 | - | -$971.30 K(-5.9%) | -$4.69 M(-7.8%) |
| Dec 2023 | -$5.09 M(-19.4%) | -$1.03 M(+1.3%) | -$5.09 M(-10.5%) |
| Sep 2023 | - | -$1.02 M(-38.9%) | -$5.69 M(-7.5%) |
| Jun 2023 | - | -$1.67 M(+22.0%) | -$6.15 M(+2.0%) |
| Mar 2023 | - | -$1.37 M(-16.2%) | -$6.02 M(-4.6%) |
| Dec 2022 | -$6.31 M(-6.2%) | -$1.63 M(+10.4%) | -$6.31 M(-5.9%) |
| Sep 2022 | - | -$1.48 M(-4.4%) | -$6.71 M(+3.7%) |
| Jun 2022 | - | -$1.55 M(-6.7%) | -$6.47 M(-2.8%) |
| Mar 2022 | - | -$1.66 M(-18.4%) | -$6.66 M(-1.0%) |
| Dec 2021 | -$6.73 M(+106.1%) | -$2.03 M(+63.8%) | -$6.73 M(+20.0%) |
| Sep 2021 | - | -$1.24 M(-28.5%) | -$5.61 M(-6.1%) |
| Jun 2021 | - | -$1.73 M(+0.4%) | -$5.97 M(+29.5%) |
| Mar 2021 | - | -$1.73 M(+90.4%) | -$4.61 M(+41.2%) |
| Dec 2020 | -$3.26 M(+33.8%) | -$906.90 K(-43.4%) | -$3.26 M(+21.8%) |
| Sep 2020 | - | -$1.60 M(+329.3%) | -$2.68 M(+24.2%) |
| Jun 2020 | - | -$373.10 K(-2.6%) | -$2.16 M(-9.9%) |
| Mar 2020 | - | -$383.20 K(+19.0%) | -$2.39 M(-1.9%) |
| Dec 2019 | -$2.44 M(+14.4%) | -$322.10 K(-70.2%) | -$2.44 M(-1.1%) |
| Sep 2019 | - | -$1.08 M(+76.8%) | -$2.47 M(+1.9%) |
| Jun 2019 | - | -$610.50 K(+42.4%) | -$2.42 M(+11.0%) |
| Mar 2019 | - | -$428.70 K(+23.0%) | -$2.18 M(+2.3%) |
| Dec 2018 | -$2.13 M(+18.0%) | -$348.60 K(-66.3%) | -$2.13 M(-3.8%) |
| Sep 2018 | - | -$1.03 M(+178.4%) | -$2.22 M(+34.7%) |
| Jun 2018 | - | -$371.40 K(-2.1%) | -$1.65 M(+5.0%) |
| Mar 2018 | - | -$379.20 K(-12.3%) | -$1.57 M(-13.3%) |
| Dec 2017 | -$1.81 M(-15.3%) | -$432.60 K(-6.4%) | -$1.81 M(-4.4%) |
| Sep 2017 | - | -$462.40 K(+57.9%) | -$1.89 M(-8.9%) |
| Jun 2017 | - | -$292.80 K(-52.8%) | -$2.08 M(-11.2%) |
| Mar 2017 | - | -$620.60 K(+20.2%) | -$2.34 M(+9.6%) |
| Dec 2016 | -$2.13 M(-25.2%) | -$516.30 K(-20.2%) | -$2.13 M(-4.4%) |
| Sep 2016 | - | -$646.90 K(+16.6%) | -$2.23 M(-5.6%) |
| Jun 2016 | - | -$555.00 K(+33.3%) | -$2.37 M(+2.3%) |
| Mar 2016 | - | -$416.50 K(-32.2%) | -$2.31 M(-19.0%) |
| Dec 2015 | -$2.85 M | -$613.90 K(-21.3%) | -$2.85 M(+0.7%) |
| Sep 2015 | - | -$779.70 K(+55.7%) | -$2.83 M(+10.9%) |
| Jun 2015 | - | -$500.70 K(-47.7%) | -$2.55 M(-8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | -$957.90 K(+61.1%) | -$2.80 M(+1.1%) |
| Dec 2014 | -$2.77 M(+101.2%) | -$594.70 K(+18.6%) | -$2.77 M(+9.3%) |
| Sep 2014 | - | -$501.40 K(-32.4%) | -$2.53 M(+8.0%) |
| Jun 2014 | - | -$741.30 K(-20.2%) | -$2.34 M(+18.9%) |
| Mar 2014 | - | -$928.80 K(+158.7%) | -$1.97 M(+43.3%) |
| Dec 2013 | -$1.37 M(-61.6%) | -$359.00 K(+14.7%) | -$1.37 M(+6.4%) |
| Sep 2013 | - | -$313.10 K(-15.1%) | -$1.29 M(-56.3%) |
| Jun 2013 | - | -$368.80 K(+10.5%) | -$2.96 M(-11.0%) |
| Mar 2013 | - | -$333.90 K(+21.1%) | -$3.32 M(-7.2%) |
| Dec 2012 | -$3.58 M(+73.1%) | -$275.70 K(-86.1%) | -$3.58 M(-9.9%) |
| Sep 2012 | - | -$1.98 M(+169.5%) | -$3.97 M(+47.4%) |
| Jun 2012 | - | -$734.00 K(+24.0%) | -$2.70 M(+16.7%) |
| Mar 2012 | - | -$591.90 K(-11.7%) | -$2.31 M(+11.6%) |
| Dec 2011 | -$2.07 M(+134.9%) | -$670.10 K(-4.1%) | -$2.07 M(+66.7%) |
| Sep 2011 | - | -$699.10 K(+101.0%) | -$1.24 M(+34.9%) |
| Jun 2011 | - | -$347.80 K(-0.9%) | -$919.20 K(+4.3%) |
| Mar 2011 | - | -$351.00 K(-322.7%) | -$881.10 K(+0.1%) |
| Dec 2010 | -$880.20 K(-43.3%) | $157.60 K(-141.7%) | -$880.30 K(-45.4%) |
| Sep 2010 | - | -$378.00 K(+22.1%) | -$1.61 M(-4.4%) |
| Jun 2010 | - | -$309.70 K(-11.6%) | -$1.69 M(+4.1%) |
| Mar 2010 | - | -$350.20 K(-39.2%) | -$1.62 M(+4.6%) |
| Dec 2009 | -$1.55 M(+22.0%) | -$575.80 K(+27.1%) | -$1.55 M(+25.4%) |
| Sep 2009 | - | -$453.10 K(+86.5%) | -$1.24 M(-3.4%) |
| Jun 2009 | - | -$243.00 K(-13.1%) | -$1.28 M(+22.2%) |
| Mar 2009 | - | -$279.60 K(+6.8%) | -$1.05 M(-17.6%) |
| Dec 2008 | -$1.27 M(-22.9%) | -$261.80 K(-47.2%) | -$1.27 M(-2.8%) |
| Sep 2008 | - | -$496.10 K(+4716.5%) | -$1.31 M(-24.5%) |
| Jun 2008 | - | -$10.30 K(-98.0%) | -$1.73 M(-8.7%) |
| Mar 2008 | - | -$503.30 K(+68.5%) | -$1.90 M(+15.2%) |
| Dec 2007 | -$1.65 M(+193.3%) | -$298.70 K(-67.6%) | -$1.65 M(+5.2%) |
| Sep 2007 | - | -$921.00 K(+424.2%) | -$1.57 M(+107.6%) |
| Jun 2007 | - | -$175.70 K(-30.6%) | -$754.80 K(-4.2%) |
| Mar 2007 | - | -$253.10 K(+16.6%) | -$788.10 K(+40.2%) |
| Dec 2006 | -$562.10 K(+1608.5%) | -$217.10 K(+99.4%) | -$562.10 K(+62.9%) |
| Sep 2006 | - | -$108.90 K(-47.9%) | -$345.00 K(+46.1%) |
| Jun 2006 | - | -$209.00 K(+671.2%) | -$236.10 K(+771.2%) |
| Mar 2006 | - | -$27.10 K | -$27.10 K |
| Dec 2005 | -$32.90 K | - | - |
FAQ
- What is Lixte Biotechnology Holdings annual net profit?
- What is the all time high annual net income for Lixte Biotechnology Holdings?
- What is Lixte Biotechnology Holdings annual net income year-on-year change?
- What is Lixte Biotechnology Holdings quarterly net profit?
- What is the all time high quarterly net income for Lixte Biotechnology Holdings?
- What is Lixte Biotechnology Holdings quarterly net income year-on-year change?
- What is Lixte Biotechnology Holdings TTM net profit?
- What is the all time high TTM net income for Lixte Biotechnology Holdings?
- What is Lixte Biotechnology Holdings TTM net income year-on-year change?
What is Lixte Biotechnology Holdings annual net profit?
The current annual net income of LIXT is -$5.09 M
What is the all time high annual net income for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high annual net profit is -$32.90 K
What is Lixte Biotechnology Holdings annual net income year-on-year change?
Over the past year, LIXT annual net profit has changed by +$1.23 M (+19.41%)
What is Lixte Biotechnology Holdings quarterly net profit?
The current quarterly net income of LIXT is -$986.00 K
What is the all time high quarterly net income for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high quarterly net profit is $157.60 K
What is Lixte Biotechnology Holdings quarterly net income year-on-year change?
Over the past year, LIXT quarterly net profit has changed by $0.00 (0.00%)
What is Lixte Biotechnology Holdings TTM net profit?
The current TTM net income of LIXT is -$4.00 M
What is the all time high TTM net income for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high TTM net profit is -$27.10 K
What is Lixte Biotechnology Holdings TTM net income year-on-year change?
Over the past year, LIXT TTM net profit has changed by $0.00 (0.00%)